PT  - JOURNAL ARTICLE
AU  - Hoyle, Brian
ED  - Heller, Simon
TI  - Liraglutide is a Safe and Beneficial Adjunct to Insulin in Glycemic Control in Type 1 Diabetes
DP  - 2013 Dec 01
TA  - MD Conference Express
PG  - 9--10
VI  - 13
IP  - 17
4099  - http://mdc.sagepub.com/content/13/17/9.2.short
4100  - http://mdc.sagepub.com/content/13/17/9.2.full
AB  - This article reports on the short-term findings of a randomized, double-blind, placebo-controlled crossover trial that demonstrated the prowess of the glucagon-like peptide-1 analogue liraglutide, used as an adjunct to insulin, in promoting glycemic control in type 1 diabetes [Heller SR et al. EASD 2013 (abstr 3); NCT01536665].